Search research articles
Contact Us
Filters
Showing results (251-260 of 267) with videos related to
Page
of 27
Sort By:
BMC Cancer
|
February 2, 2018
Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT
Shan-Shan Guo, Wen Hu, Qiu-Yan Chen, et al.
Journal of Extracellular Vesicles
|
March 4, 2026
An Extracellular Vesicle Protein-Based Machine Learning Framework for Early Detection of Oesophageal Squamous Cell Carcinoma: A Multicentre, Prospective Study
Yu Wang, Shan Xing, Ya-Xian Wu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 9, 2014
High-sensitivity C-reactive protein complements plasma Epstein-Barr virus deoxyribonucleic acid prognostication in nasopharyngeal carcinoma: a large-scale retrospective and prospective cohort study
Lin-Quan Tang, Chao-Feng Li, Qiu-Yan Chen, et al.
Nature
|
April 15, 2026
EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk
Yanhong Chen, Jingtong Liang, Wanlin Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 2, 2022
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion
Xiao Zhang, Junping Hong, Ling Zhong, et al.
Cell Host & Microbe
|
October 17, 2023
A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV
Cong Sun, Yin-Feng Kang, Xin-Yan Fang, et al.
Cell Research
|
September 9, 2020
Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma
Shanzhao Jin, Ruoyan Li, Ming-Yuan Chen, et al.
Nature Genetics
|
June 19, 2019
Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma
Miao Xu, Youyuan Yao, Hui Chen, et al.
Nature
|
June 18, 2025
R9AP is a common receptor for EBV infection in epithelial cells and B cells
Yan Li, Hua Zhang, Cong Sun, et al.
The Journal of Clinical Investigation
|
November 26, 2024
A large-scale population-based study reveals that gp42-IgG antibody is protective against EBV-associated nasopharyngeal carcinoma
Xiang-Wei Kong, Guo-Long Bu, Hua Chen, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 267) with videos related to
Sort By:
Page
of 27
BMC Cancer
|
February 2, 2018
Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT
Shan-Shan Guo, Wen Hu, Qiu-Yan Chen, et al.
Journal of Extracellular Vesicles
|
March 4, 2026
An Extracellular Vesicle Protein-Based Machine Learning Framework for Early Detection of Oesophageal Squamous Cell Carcinoma: A Multicentre, Prospective Study
Yu Wang, Shan Xing, Ya-Xian Wu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 9, 2014
High-sensitivity C-reactive protein complements plasma Epstein-Barr virus deoxyribonucleic acid prognostication in nasopharyngeal carcinoma: a large-scale retrospective and prospective cohort study
Lin-Quan Tang, Chao-Feng Li, Qiu-Yan Chen, et al.
Nature
|
April 15, 2026
EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk
Yanhong Chen, Jingtong Liang, Wanlin Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 2, 2022
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion
Xiao Zhang, Junping Hong, Ling Zhong, et al.
Cell Host & Microbe
|
October 17, 2023
A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV
Cong Sun, Yin-Feng Kang, Xin-Yan Fang, et al.
Cell Research
|
September 9, 2020
Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma
Shanzhao Jin, Ruoyan Li, Ming-Yuan Chen, et al.
Nature Genetics
|
June 19, 2019
Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma
Miao Xu, Youyuan Yao, Hui Chen, et al.
Nature
|
June 18, 2025
R9AP is a common receptor for EBV infection in epithelial cells and B cells
Yan Li, Hua Zhang, Cong Sun, et al.
The Journal of Clinical Investigation
|
November 26, 2024
A large-scale population-based study reveals that gp42-IgG antibody is protective against EBV-associated nasopharyngeal carcinoma
Xiang-Wei Kong, Guo-Long Bu, Hua Chen, et al.
Page
of 27